Ophthalmology, Retina Specialist · Shreveport, LA
NPI
1558380303
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
836 Olive St
Shreveport, LA, 71104
Phone (318) 222-8421
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
29,611 services
Medicare patients, 2024
1,289
Average age 78
Drug cost, 2024
$37K
829 prescriptions
Company payments, 2025
$300
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles E Lyon was code J2777 (injection, faricimab-svoa, 0.1 mg), 12,240 times for 42 patients. In total Charles E Lyon billed 29,611 services in 25 codes, and Medicare paid $2.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 12,240 | 42 | $26.08 | $319K |
| 92134 Computerized Ophthalmic Imaging | Office | 3,871 | 1,150 | $25.34 | $98K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 3,825 | 67 | $115.07 | $440K |
| 99214 Office E&M - Established | Office | 3,654 | 1,098 | $76.84 | $281K |
| 67028 Intravitreal Injection | Office | 2,043 | 506 | $71.07 | $145K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,885 | 262 | $647.06 | $1.2M |
| J0177 Injection, aflibercept hd, 1 mg | Office | 1,124 | 48 | $256.57 | $288K |
| J9035 Injection, bevacizumab, 10 mg | Office | 443 | 210 | $56.07 | $25K |
| 99204 Office E&M - New | Office | 281 | 281 | $97.12 | $27K |
| Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 65 | 12 | $114.02 | $7,411 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 28 | 15 | $0.01 | $0.26 |
| 67145 Eye | Office | 27 | 26 | $158.15 | $4,270 |
| 99213 Office E&M - Established | Office | 27 | 26 | $60.86 | $1,643 |
| 92250 Angiography | Office | 17 | 15 | $22.91 | $389 |
| 67036 Vitrectomy - Mechanical | Facility | 15 | 13 | $591.62 | $8,874 |
By year: 2022 $2.3M for 9,475 services; 2023 $2.6M for 18,096 services; 2024 $2.9M for 29,611 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles E Lyon prescribed most often to Medicare patients was Tobramycin, with 429 prescriptions and refills. In total Charles E Lyon wrote 829 Medicare prescriptions that cost $37K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tobramycin Generic | 429 | 430 | 250 | $2,266 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 51 | 121 | 15 | $977 |
| Latanoprost Generic | 51 | 66 | 14 | $562 |
| Prednisolone Acetate Generic | 38 | 64 | 19 | $3,126 |
| Ketorolac Tromethamine Generic | 34 | 43 | 13 | $853 |
| Brimonidine Tartrate Generic | 33 | 50 | Under 11 | $225 |
| Moxifloxacin Moxifloxacin Hcl | 32 | 32 | 22 | $693 |
| Ofloxacin Generic | 31 | 32 | 23 | $337 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 23 | 25 | 14 | $285 |
| Dorzolamide Hcl Generic | 19 | 34 | Under 11 | $361 |
| Prednisone Generic | 13 | 18 | Under 11 | $134 |
| Combigan Brimonidine Tartrate/Timolol | 11 | 11 | Under 11 | $2,207 |
Brand drugs: 109 claims; generic drugs: 720 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles E Lyon $300 ($300 in general payments such as food, travel and fees) from 4 companies. The largest payer was Apellis Pharmaceuticals, Inc. with $139.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.